CANNAPHARMARX, INC.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | — | — |
| SG&A Expense | $91.4K | $93.6K |
| Operating Income | $585.6K | $113.7K |
| Operating Margin | — | — |
| Interest Expense | — | — |
| Pretax Income | $575.4K | $108.9K |
| Income Tax Expense | — | — |
| Net Income | $575.4K | $108.9K |
| Net Margin | — | — |
| EPS (Basic) | $0.04 | — |
| EPS (Diluted) | $0.04 | — |
| Shares Outstanding (Basic) | 14.3M | 14.2M |
| Shares Outstanding (Diluted) | 14.3M | 14.2M |
| Dividends Per Share | — | — |